First person – Mark Hanson

Abstract

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Mark Hanson is first author on ‘ Antimicrobial peptides do not directly contribute to aging in Drosophila, but improve lifespan by preventing dysbiosis’, published in DMM. Mark conducted the research described in this article while working as a postdoctoral researcher in Prof. Bruno Lemaitre's lab at École Polytechnique Fédérale de Lausanne (EPFL), Switzerland. He is now a Research Fellow in the lab of Prof. Ben Longdon at University of Exeter, Penryn, UK, investigating the evolution of immune systems to learn how our body's defences are adapted to the world around them.